Repligen Corp
(NAS:RGEN)
$
163.92
+4.46 (+2.8%)
Market Cap: 9.25 Bil
Enterprise Value: 9.13 Bil
PE Ratio: 224.55
PB Ratio: 4.38
GF Score: 90/100 Repligen Corp at Stifel Healthcare Conference Transcript
Nov 15, 2023 / 01:00PM GMT
Release Date Price:
$155.93
(+1.39%)
Daniel Anthony Arias
Stifel, Nicolaus & Company, Incorporated, Research Division - MD & Senior Analyst
Okay. Welcome, everybody, to day 2 of the 2023 Stifel Healthcare Conference. This is a life sciences and diagnostics track. We're happy to kick things off this morning with Repligen. I have CEO, Tony Hunt; and CFO, Jason Garland, with me here. Guys, thanks very much for spending some time this morning.
Anthony J. Hunt
Repligen Corporation - CEO & Director
Good morning.
Jason K. Garland
Repligen Corporation - CFO
Yes. Good to hear.
Questions & Answers
Daniel Anthony Arias;Jason K.
Stifel, Nicolaus & Company, Incorporated, Research Division - MD & Senior Analyst
Jason, maybe since this is our first time getting to chat with you in a public forum, I'll just start with you, if I can. You arrived at the company a couple of months ago. What at a high level would you say you've been spending most of your time focusing on?
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot